Babinčák, M.; Jendželovský, R.; Košuth, J.; Majerník, M.; Vargová, J.; Mikulášek, K.; Zdráhal, Z.; Fedoročko, P.
Death Receptor 5 (TNFRSF10B) Is Upregulated and TRAIL Resistance Is Reversed in Hypoxia and Normoxia in Colorectal Cancer Cell Lines after Treatment with Skyrin, the Active Metabolite of Hypericum spp. Cancers 2021, 13, 1646.
https://doi.org/10.3390/cancers13071646
AMA Style
Babinčák M, Jendželovský R, Košuth J, Majerník M, Vargová J, Mikulášek K, Zdráhal Z, Fedoročko P.
Death Receptor 5 (TNFRSF10B) Is Upregulated and TRAIL Resistance Is Reversed in Hypoxia and Normoxia in Colorectal Cancer Cell Lines after Treatment with Skyrin, the Active Metabolite of Hypericum spp. Cancers. 2021; 13(7):1646.
https://doi.org/10.3390/cancers13071646
Chicago/Turabian Style
Babinčák, Marián, Rastislav Jendželovský, Ján Košuth, Martin Majerník, Jana Vargová, Kamil Mikulášek, Zbyněk Zdráhal, and Peter Fedoročko.
2021. "Death Receptor 5 (TNFRSF10B) Is Upregulated and TRAIL Resistance Is Reversed in Hypoxia and Normoxia in Colorectal Cancer Cell Lines after Treatment with Skyrin, the Active Metabolite of Hypericum spp." Cancers 13, no. 7: 1646.
https://doi.org/10.3390/cancers13071646
APA Style
Babinčák, M., Jendželovský, R., Košuth, J., Majerník, M., Vargová, J., Mikulášek, K., Zdráhal, Z., & Fedoročko, P.
(2021). Death Receptor 5 (TNFRSF10B) Is Upregulated and TRAIL Resistance Is Reversed in Hypoxia and Normoxia in Colorectal Cancer Cell Lines after Treatment with Skyrin, the Active Metabolite of Hypericum spp. Cancers, 13(7), 1646.
https://doi.org/10.3390/cancers13071646